Clinical Trials Directory

Trials / Conditions / Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7

Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7

12 registered clinical trials studyying Stage IVA Oropharyngeal Squamous Cell Carcinoma AJCC v7.

StatusTrialSponsorPhase
Active Not RecruitingIpilimumab, Nivolumab, and Radiation Therapy in Treating Patients With HPV Positive Advanced Oropharyngeal Squ
NCT03799445
M.D. Anderson Cancer CenterPhase 2
TerminatedAlpelisib in Treating Participants With Transorally Resectable HPV-Associated Stage I-IVA Oropharyngeal Cancer
NCT03601507
University of ArizonaPhase 2
Active Not RecruitingPembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer
NCT03468218
Emory UniversityPhase 2
TerminatedACTOplus Met XR in Treating Patients With Stage I-IV Oral Cavity or Oropharynx Cancer Undergoing Definitive Tr
NCT02917629
National Cancer Institute (NCI)Phase 2
CompletedDurvalumab With or Without Tremelimumab in Treating Participants With Stage II-IVA Oropharyngeal Squamous Cell
NCT03144778
M.D. Anderson Cancer CenterPhase 1
CompletedCisplatin, Intensity-Modulated Radiation Therapy, and Pembrolizumab in Treating Patients With Stage III-IV Hea
NCT02775812
National Cancer Institute (NCI)Phase 1
CompletedOnalespib in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Recei
NCT02381535
National Cancer Institute (NCI)Phase 1
Active Not RecruitingIntensity-Modulated Proton Beam Therapy or Intensity-Modulated Photon Therapy in Treating Patients With Stage
NCT01893307
M.D. Anderson Cancer CenterPhase 3
CompletedIpilimumab, Cetuximab, and Intensity-Modulated Radiation Therapy in Treating Patients With Previously Untreate
NCT01935921
National Cancer Institute (NCI)Phase 1
CompletedLenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck Cancer
NCT01254617
National Cancer Institute (NCI)Phase 1
CompletedCombination Chemotherapy With or Without Erlotinib Hydrochloride in Treating Patients With Metastatic or Recur
NCT01064479
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingChemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squam
NCT00588770
National Cancer Institute (NCI)Phase 3